Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Cattran

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Kidney International|August 17, 2016
The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseasesMarie C Hogan, Heather N Reich, Peter J Nelson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 17, 2019
Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGSTony Yao, Khalil Udwan, Rohan John, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceBrad H Rovin, Dawn J Caster, Daniel C Cattran, et al.
Plos One|October 27, 2010
A molecular signature of proteinuria in glomerulonephritisHeather N Reich, David Tritchler, Daniel C Cattran, et al.
Kidney International|May 6, 2011
Validation of the Oxford classification of IgA nephropathyAndrew M Herzenberg, Agnes B Fogo, Heather N Reich, et al.
Kidney International Reports|July 18, 2025
Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1283-1287]Sean J Barbour, Rosanna Coppo, Jonathan Barratt, et al.
Kidney International Reports|April 30, 2025
Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial CohortsSean J Barbour, Rosanna Coppo, Jonathan Barratt, et al.
Kidney International|May 29, 2020
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction ToolSean J Barbour, Mark Canney, Rosanna Coppo, et al.
Kidney International Reports|August 15, 2025
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With RituximabMaria J Vargas-Brochero, Elisabeth Lafaut, Yeshwanter Radhakrishnan, et al.
BMC Medical Informatics and Decision Making|June 8, 2012
Glomerular disease search filters for Pubmed, Ovid Medline, and Embase: a development and validation studyAinslie M Hildebrand, Arthur V Iansavichus, Christopher W C Lee, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Kidney International|August 17, 2016
The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseasesMarie C Hogan, Heather N Reich, Peter J Nelson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 17, 2019
Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGSTony Yao, Khalil Udwan, Rohan John, et al.
Kidney International|January 23, 2019
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceBrad H Rovin, Dawn J Caster, Daniel C Cattran, et al.
Plos One|October 27, 2010
A molecular signature of proteinuria in glomerulonephritisHeather N Reich, David Tritchler, Daniel C Cattran, et al.
Kidney International|May 6, 2011
Validation of the Oxford classification of IgA nephropathyAndrew M Herzenberg, Agnes B Fogo, Heather N Reich, et al.
Kidney International Reports|July 18, 2025
Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1283-1287]Sean J Barbour, Rosanna Coppo, Jonathan Barratt, et al.
Kidney International Reports|April 30, 2025
Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial CohortsSean J Barbour, Rosanna Coppo, Jonathan Barratt, et al.
Kidney International|May 29, 2020
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction ToolSean J Barbour, Mark Canney, Rosanna Coppo, et al.
Kidney International Reports|August 15, 2025
Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With RituximabMaria J Vargas-Brochero, Elisabeth Lafaut, Yeshwanter Radhakrishnan, et al.
BMC Medical Informatics and Decision Making|June 8, 2012
Glomerular disease search filters for Pubmed, Ovid Medline, and Embase: a development and validation studyAinslie M Hildebrand, Arthur V Iansavichus, Christopher W C Lee, et al.
Pageof 11